Mutagenicity and tumorigenicity of the four enantiopure bay-region 3,4-diol-1,2-epoxide isomers of dibenz[a,h]anthracene
- PMID: 23671133
- PMCID: PMC3765047
- DOI: 10.1093/carcin/bgt164
Mutagenicity and tumorigenicity of the four enantiopure bay-region 3,4-diol-1,2-epoxide isomers of dibenz[a,h]anthracene
Abstract
Each enantiomer of the diastereomeric pair of bay-region dibenz[a,h]anthracene 3,4-diol-1,2-epoxides in which the benzylic 4-hydroxyl group and epoxide oxygen are either cis (isomer 1) or trans (isomer 2) were evaluated for mutagenic activity. In strains TA 98 and TA 100 of Salmonella typhimurium, the diol epoxide with (1S,2R,3S,4R) absolute configuration [(-)-diol epoxide-1] had the highest mutagenic activity. In Chinese hamster V-79 cells, the diol epoxide with (1R,2S,3S,4R) absolute configuration [(+)-diol epoxide-2] had the highest mutagenic activity. The (1R,2S,3R,4S) diol epoxide [(+)-diol epoxide-1] also had appreciable activity, whereas the other two bay-region diol epoxide enantiomers had very low activity. In tumor studies, the (1R,2S,3S,4R) enantiomer was the only diol epoxide isomer tested that had strong activity as a tumor initiator on mouse skin and in causing lung and liver tumors when injected into newborn mice. This stereoisomer was about one-third as active as the parent hydrocarbon, dibenz[a,h]anthracene as a tumor initiator on mouse skin; it was several-fold more active than dibenz[a,h]anthracene as a lung and liver carcinogen when injected into newborn mice. (-)-(3R,4R)-3β,4α-dihydroxy-3,4-dihydro-dibenz[a,h]anthracene [(-)-3,4-dihydrodiol] was slightly more active than dibenz[a,h]anthracene as a tumor initiator on mouse skin, whereas (+)-(3S,4S)-3α,4β-dihydroxy-3,4-dihydro-dibenz[a,h]anthracene [(+)-3,4-dihydrodiol] had only very weak activity. The present investigation and previous studies with the corresponding four possible enantiopure bay-region diol epoxide enantiomers/diastereomers of benzo[a]pyrene, benz[a]anthracene, chrysene, benzo[c]phenanthrene, dibenz[c,h]acridine, dibenz[a,h]acridine and dibenz[a,h]anthracene indicate that the bay-region diol epoxide enantiomer with [R,S,S,R] absolute stereochemistry has high tumorigenic activity on mouse skin and in newborn mice.
Figures



Similar articles
-
Bacterial and mammalian cell mutagenicity of four optically active bay-region 3,4-diol-1,2-epoxides and other derivatives of the nitrogen heterocycle dibenz[c,h]acridine.Cancer Res. 1986 Jun;46(6):2760-6. Cancer Res. 1986. PMID: 3516386
-
Tumorigenicity of four optically active bay-region 3,4-diol 1, 2-epoxides and other derivatives of the nitrogen heterocycle dibenz[c,h]acridine on mouse skin and in newborn mice.Carcinogenesis. 2000 Nov;21(11):1997-2003. doi: 10.1093/carcin/21.11.1997. Carcinogenesis. 2000. PMID: 11062160
-
Mutagenicity of the enantiomers of the diastereomeric bay-region benz(a)anthracene 3,4-diol-1,2-epoxides in bacterial and mammalian cells.Cancer Res. 1983 Dec;43(12 Pt 1):5821-5. Cancer Res. 1983. PMID: 6357432
-
Dose-dependent differences in the profile of mutations induced by carcinogenic (R,S,S,R) bay- and fjord-region diol epoxides of polycyclic aromatic hydrocarbons.Adv Exp Med Biol. 2001;500:697-707. doi: 10.1007/978-1-4615-0667-6_102. Adv Exp Med Biol. 2001. PMID: 11765016 Review.
-
Relationships of quantum mechanical calculations, relative mutagenicity of benzo[a]anthracene diol epoxides, and "bay region" concept of aromatic hydrocarbon carcinogenicity.J Toxicol Environ Health. 1977 Jul;2(6):1259-65. doi: 10.1080/15287397709529528. J Toxicol Environ Health. 1977. PMID: 328916 Review.
Cited by
-
Toluene Dioxygenase-Catalyzed cis-Dihydroxylation of Quinolines: A Molecular Docking Study and Chemoenzymatic Synthesis of Quinoline Arene Oxides.Front Bioeng Biotechnol. 2021 Feb 12;8:619175. doi: 10.3389/fbioe.2020.619175. eCollection 2020. Front Bioeng Biotechnol. 2021. PMID: 33644006 Free PMC article.
-
Risk-based in silico mutagenic assessment of benzodiazepine impurities using three QSAR tools.Toxicol Rep. 2025 Mar 25;14:102008. doi: 10.1016/j.toxrep.2025.102008. eCollection 2025 Jun. Toxicol Rep. 2025. PMID: 40230516 Free PMC article.
-
Developmental toxicity of alkylated PAHs and substituted phenanthrenes: Structural nuances drive diverse toxicity and AHR activation.Chemosphere. 2025 Feb;370:143894. doi: 10.1016/j.chemosphere.2024.143894. Epub 2024 Dec 10. Chemosphere. 2025. PMID: 39643011 Free PMC article.
-
Human aldo-keto reductases and the metabolic activation of polycyclic aromatic hydrocarbons.Chem Res Toxicol. 2014 Nov 17;27(11):1901-17. doi: 10.1021/tx500298n. Epub 2014 Oct 16. Chem Res Toxicol. 2014. PMID: 25279998 Free PMC article. Review.
-
Carcinogenic polycyclic aromatic hydrocarbons induce CYP1A1 in human cells via a p53-dependent mechanism.Arch Toxicol. 2016 Feb;90(2):291-304. doi: 10.1007/s00204-014-1409-1. Epub 2014 Nov 15. Arch Toxicol. 2016. PMID: 25398514 Free PMC article.
References
-
- Jerina D.M, et al. (1974). Arene oxides: a new aspect of drug metabolism. Science, 185, 573–582 - PubMed
-
- Miller E.C, et al. (1974). Biochemical mechanisms of chemical carcinognesisIn Bush H. (ed.) Molecular Biology of Cancer, Academic Press, New York, pp. 377–402
-
- Miller J.A. (1970). Carcinogenesis by chemicals: an overview–G. H. A. Clowes memorial lecture. Cancer Res., 30, 559–576 - PubMed
-
- Sims P, et al. (1974). Epoxides in polycyclic aromatic hydrocarbon metabolism and carcinogenesis. Adv. Cancer Res., 20, 165–274 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases